M. Peck-Radosavljevic Et Al. , "Use of low-dose peginterferon alpha-2a (40kD) 628 (pegasys (R)) to treat hepatitis C-infected end-stage renal disease patients undergoing haemodialysis: Interim results from a randomised study," 42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , vol.46, Barcelona, Spain, 2007
Peck-Radosavljevic, M. Et Al. 2007. Use of low-dose peginterferon alpha-2a (40kD) 628 (pegasys (R)) to treat hepatitis C-infected end-stage renal disease patients undergoing haemodialysis: Interim results from a randomised study. 42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , (Barcelona, Spain).
Peck-Radosavljevic, M., Boletis, J., Besisik, F., Ferraz, M. L., Alric, L., Samuel, D., ... Messinger, D.(2007). Use of low-dose peginterferon alpha-2a (40kD) 628 (pegasys (R)) to treat hepatitis C-infected end-stage renal disease patients undergoing haemodialysis: Interim results from a randomised study . 42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Barcelona, Spain
Peck-Radosavljevic, M. Et Al. "Use of low-dose peginterferon alpha-2a (40kD) 628 (pegasys (R)) to treat hepatitis C-infected end-stage renal disease patients undergoing haemodialysis: Interim results from a randomised study," 42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Barcelona, Spain, 2007
Peck-Radosavljevic, M. Et Al. "Use of low-dose peginterferon alpha-2a (40kD) 628 (pegasys (R)) to treat hepatitis C-infected end-stage renal disease patients undergoing haemodialysis: Interim results from a randomised study." 42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , Barcelona, Spain, 2007
Peck-Radosavljevic, M. Et Al. (2007) . "Use of low-dose peginterferon alpha-2a (40kD) 628 (pegasys (R)) to treat hepatitis C-infected end-stage renal disease patients undergoing haemodialysis: Interim results from a randomised study." 42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , Barcelona, Spain.
@conferencepaper{conferencepaper, author={M. Peck-Radosavljevic Et Al. }, title={Use of low-dose peginterferon alpha-2a (40kD) 628 (pegasys (R)) to treat hepatitis C-infected end-stage renal disease patients undergoing haemodialysis: Interim results from a randomised study}, congress name={42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver}, city={Barcelona}, country={Spain}, year={2007}}